Announcing the Appian World 2018 Online Hackathon
Feb 26, 2018 13:01 pm UTC| Business
RESTON, Va., Feb. 26, 2018 -- Appian (NASDAQ:APPN) is offering up to $10,000 for the winning projects in the Appian World 2018 Hackathon. The online Hackathon, open now and accepting submissions through March 27, will...
21Vianet Group, Inc. to Announce Fourth Quarter and Full Year 2017 Financial Results
Feb 26, 2018 13:01 pm UTC| Business
BEIJING, Feb. 26, 2018 -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its fourth...
Targa Resources Partners LP Announces 2017 Schedules K-1 Available
Feb 26, 2018 13:01 pm UTC| Business
HOUSTON, Feb. 26, 2018 -- Targa Resources Partners LP (“Targa Resources Partners” or the “Partnership”) today announced that it has completed the 2017 tax packages for the holders of Targa Resources Partners 9% Series A...
Feb 26, 2018 13:00 pm UTC| Business
VANCOUVER, British Columbia, Feb. 26, 2018 -- Skyharbour Resources Ltd. (TSX-V:SYH) (OTCQB:SYHBF) (Frankfurt:SC1P) (the “Company”) is pleased to announce it has commenced its winter 2018 diamond drilling program at its...
Elite Data Announces Name Change
Feb 26, 2018 13:00 pm UTC| Business
DENVER, Feb. 26, 2018 -- via OTCPR WIRE--Elite Data Services, Inc. (OTC:DEAC) announces that pursuant to shareholder consent, the Company has changed its name to WOD Retail Solutions, Inc. with the State of Florida and...
Feb 26, 2018 13:00 pm UTC| Business
– Phase 3 VISION Trial Design Finalized for 177Lu-PSMA-617 Following Successful End of Phase 2 Meeting with the FDA – – Announced Agreement for Clinical Supply of No-Carrier-Added Lutetium with ITM – ...
ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial
Feb 26, 2018 13:00 pm UTC| Business
-------------------------------------------------------------------------------------------------- Gencaro Demonstrates Comparable Efficacy to Active Control and Trend for Potential Gencaro Superiority in US Patient...